Grant R. Wilkinson

Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.

R. Kim, G. Wilkinson, D. O'Shea, 1994, Pharmacogenetics.

Amiodarone dosing: a proposal based on its pharmacokinetics.

D. Roden, R. Woosley, G. Wilkinson, 1983, American Heart Journal.

Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

Mark M. Roden, R. Kim, G. Wilkinson, 1999, The Journal of pharmacology and experimental therapeutics.